Patrick Wingrove

1 week ago | msn.com | Patrick Wingrove

Microsoft Cares About Your PrivacyMicrosoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will personalise the content and ads that you see. You can select ‘I Accept’ to consent to these uses or click on ‘Manage preferences’ to review your options and exercise your right to object to Legitimate Interest where used.

2 weeks ago | ca.finance.yahoo.com | Patrick Wingrove

By Patrick Wingrove (Reuters) -Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it grapples with renewed threats of drug import duties from the Trump administration. The drugmaker plans to build six new manufacturing plants, some of which will make raw pharmaceutical ingredients, as well as a new research and development site in San Diego, California, the company said.

2 weeks ago | terra.com.br | Patrick Wingrove

A Novartis anunciou nesta quinta-feira que planeja investir US$23 bilhões na construção e expansão de 10 instalações nos Estados Unidos, enquanto enfrenta novas ameaças do governo Trump de tarifas sobre a importação de medicamentos. A farmacêutica pretende construir seis novas fábricas, algumas das quais produzirão ingredientes farmacêuticos ativos, além de um novo centro de pesquisa e desenvolvimento em San Diego, Califórnia, informou a farmacêutica suíça.

4 weeks ago | streetinsider.com | Patrick Wingrove

1. GM2. SPY3. TSLA4. F5. GME6. DLTR7. WOOF8. DOOO9. CHWY10. NIO Tweet Share E-mail0 shares FILE PHOTO: Cigarettes are displayed in a store in New York March 30, 2010. By Patrick Wingrove (Reuters) -Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet deadlines mandated by Congress due to Trump administration layoffs, three scientists working on the projects told Reuters.

4 weeks ago | today.westlaw.com | Bill Berkrot |Michele Gershberg |Patrick Wingrove |Caroline Humer

(Reuters) -Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet deadlines mandated by Congress due to Trump administration layoffs, three scientists working on the projects told...